Core Viewpoint - China Resources Double Crane announced participation in the 11th national centralized drug procurement, with several products expected to be selected for procurement [1] Group 1: Selected Products - The products expected to be selected include Methoclopramide injection, Meprobamate injection, Famotidine injection, and Piracetam oral sustained-release formulation [1] - The proposed procurement prices are as follows: Methoclopramide injection at 0.68 CNY per unit, Meprobamate injection at 9.78 CNY per unit, Famotidine injection at 0.42 CNY per unit, and Piracetam oral sustained-release formulation at 7.87 CNY per bottle [1]